Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Smith

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
JMIR Public Health and Surveillance|May 8, 2023
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled TrialA Brianne Bota, Julie A Bettinger, Shirley Sarfo-Mensah, et al.
BJU International|August 22, 2025
Treatment variations in localised prostate cancer in Australia and New Zealand: a registry studyKaren Chiam, Albert Bang, Visalini Nair-Shalliker, et al.
Human Vaccines & Immunotherapeutics|February 20, 2024
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network studyMohamed Serhan, Athanasios Psihogios, Nooh Kabir, et al.
BMJ Open|March 23, 2024
Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)Anna Green, Robert U Newton, David P Smith, et al.
JCO Oncology Practice|September 24, 2020
Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate CancerTahlia Scheinberg, Annabel Goodwin, Emilia Ip, et al.
Journal of the National Cancer Institute|November 12, 2025
Disparities in cancer survival by socioeconomic status: findings from a population-based study of 942,241 Australians from 1980 to 2019Sarsha Yap, Qingwei Luo, Jeff Cuff, et al.
Cancer Epidemiology|November 5, 2013
Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007Freddy Sitas, Alison Gibberd, Clare Kahn, et al.
BMJ Open|March 3, 2021
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trialVisalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Science Bulletin|January 21, 2026
Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries/territories in 2022Ping Li, Zhan Ding, Yuqi Feng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2005
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathwayRoberto Cappai, Su-Ling Leck, Deborah J Tew, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
JMIR Public Health and Surveillance|May 8, 2023
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled TrialA Brianne Bota, Julie A Bettinger, Shirley Sarfo-Mensah, et al.
BJU International|August 22, 2025
Treatment variations in localised prostate cancer in Australia and New Zealand: a registry studyKaren Chiam, Albert Bang, Visalini Nair-Shalliker, et al.
Human Vaccines & Immunotherapeutics|February 20, 2024
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network studyMohamed Serhan, Athanasios Psihogios, Nooh Kabir, et al.
BMJ Open|March 23, 2024
Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)Anna Green, Robert U Newton, David P Smith, et al.
JCO Oncology Practice|September 24, 2020
Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate CancerTahlia Scheinberg, Annabel Goodwin, Emilia Ip, et al.
Journal of the National Cancer Institute|November 12, 2025
Disparities in cancer survival by socioeconomic status: findings from a population-based study of 942,241 Australians from 1980 to 2019Sarsha Yap, Qingwei Luo, Jeff Cuff, et al.
Cancer Epidemiology|November 5, 2013
Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007Freddy Sitas, Alison Gibberd, Clare Kahn, et al.
BMJ Open|March 3, 2021
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trialVisalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Science Bulletin|January 21, 2026
Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries/territories in 2022Ping Li, Zhan Ding, Yuqi Feng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2005
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathwayRoberto Cappai, Su-Ling Leck, Deborah J Tew, et al.
Pageof 17